Home
Conditions
Severe Dengue

Clinical trial condition

Severe Dengue

Explore clinical trials studying Severe Dengue. Study availability and eligibility vary by location and protocol.

59 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Severe Dengue trial results

Completed

Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients

NCT04673422

Conditions: Arbovirus Infections, Dengue, Dengue Shock Syndrome, +10 more
Locations: Hatyai Hospital Hat Yai, Changwat Songkhla, Thailand

Phramongkutklao Hospital Bangkok, Thailand

Ananda Mahidol Hospital Lopburi, Thailand

Fort Suranari Hospital Nakhon Ratchasima, Thailand

View Trial Details

Completed

Dengue Effectiveness Study in the Philippines

NCT03803618

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +9 more
Locations: Cebu Provincial Hospital - Balamban Balamban, Cebu, Philippines

Cebu Provincial Hospital - Bogo Bogo, Cebu, Philippines

Cebu Provincial Hospital - Danao Danao, Cebu, Philippines

Eversley Childs Sanitarium and General Hospital Mandaue City, Cebu, Philippines

View Trial Details

Completed

Efficacy and Safety of Dengue Vaccine in Healthy Children

NCT00842530

Conditions: Arbovirus Infections, Dengue, Dengue Diseases, +12 more
Locations: Sanofi Pasteur Investigational Site Bangkok, Thailand

View Trial Details

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India

NCT01550289

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Bangalore, Karnataka, India

Ludhiana, Punjab, India

Kolkata, West Bengal, India

New Delhi, India

View Trial Details

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

NCT00875524

Conditions: Arbovirus Infections, Dengue, Dengue Disease, +12 more
Locations: Sanofi Pasteur Investigational Site Long Xuyen, An Giang, Vietnam

View Trial Details

Completed

Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years

NCT00788151

Conditions: Arbovirus Infections, Dengue, Dengue Diseases, +12 more
Locations: Chulucanas Morropon, Piura, Peru

View Trial Details

Completed

Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study

NCT01983553

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Ratchaburi, Muang District, Thailand

View Trial Details

Completed

Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers

NCT01411241

Conditions: Arbovirus Infections, Dengue, Dengue Hemorrhagic Fever, +9 more
Locations: Acapulco de Juárez, Guerrero, Mexico

Guadalajara, Jalisco, Mexico

Monterrey, Nuevo León, Mexico

Mérida, Yucatán, Mexico

View Trial Details

Completed

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

NCT02993757

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +11 more
Locations: Sanofi Pasteur Investigational Site 004 Klang, Malaysia

Sanofi Pasteur Investigational Site 005 Kuala Lumpur, Malaysia

Sanofi Pasteur Investigational Site 001 Kuala Lumpur, Malaysia

Sanofi Pasteur Investigational Site 003 Kuantan, Malaysia

View Trial Details

Completed

Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia

NCT01254422

Conditions: Arbovirus Infections, Dengue, Dengue Fever, +10 more
Locations: Ipoh, Perak, Malaysia

Kuala Lumpur, Malaysia

Kuching, Sarawak, Malaysia

Negeri Sembilan, Malaysia

View Trial Details

Severe Dengue

Severe Dengue trial results

Related conditions